Antireflux stents in tumors of the cardia

Dua, Kulwinder S.

doi:10.1016/s0002-9343(01)00854-3

Cited by 10 publications

(2 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…When stents are placed across the GEJ, the stomach and the esophagus become a common cavity, thereby predisposing the patient to reflux and the risks of aspiration (reported incidence 25–80%) . Results from studies evaluating the efficacy of the currently available antireflux stents have been mixed.…”

Section: Palliation Of Malignant Dysphagia: How To Choose An Esophagementioning

confidence: 99%

Stents for benign and malignant esophageal strictures

Moura

Toma

Goh

et al. 2013

Annals of the New York Academy of Sciences

View full text Add to dashboard Cite

This paper presents commentaries on endotherapy for esophageal perforation/leaks; treatment of esophageal perforation; whether esophageal stents should be used for treating benign esophageal strictures; what determines the optimal stenting period in benign esophageal strictures/leaks; how to choose an esophageal stent; how a new fistula secondary to an esophageal stent should be treated; which strategy should be adopted when a fistula of a cervical anastomosis occurs; intralesional steroids for refractory esophageal strictures; balloon and bougie dilators for esophageal strictures and predictors of response to dilation; whether refractory strictures from different etiologies respond differently to endotherapy; surgical therapy of benign esophageal strictures; and whether stenoses following severe esophageal burns should be treated by esophageal resection or esophageal bypass.

show abstract

Section: Palliation Of Malignant Dysphagia: How To Choose An Esophagementioning

confidence: 99%

Stents for benign and malignant esophageal strictures

Moura

Toma

Goh

et al. 2013

Annals of the New York Academy of Sciences

View full text Add to dashboard Cite

show abstract

“…The stent was deployed in 13 patients and was effective in preventing reflux in every case. Following this experience, in 2001 Dua [60] published the results of its modified modified Z stent (with 'Dua' antireflux valve) tested in 11 patients affected by carcinomas at the gastroesophageal junction. He found that the modified stent was effective in preventing gastroesophageal reflux while allowing belching and vomiting.…”

Section: Antireflux Stentsmentioning

confidence: 99%

Stenting in Esophageal Strictures

Petruzziello

Costamagna²

2002

Dig Dis

View full text Add to dashboard Cite

The interventional management of esophageal strictures remains, to date, an important clinical challenge. Stenting is probably the best palliation modality in patients with incurable esophagogastric carcinoma. Conversely, the use of esophageal stents is still relatively uncommon for the treatment of refractory benign strictures. In the last few years, several new stents have become available as a result of significant advances that have been made in terms of design and materials. This review focuses on the endoscopic use of esophageal stents in malignant and benign esophageal strictures, revisiting the different types of expandable stents presently available, the techniques, the results, and the complications of stent insertion and giving some practical advices. Future developments in the field of esophageal stenting are also discussed.

show abstract

Interventionelle palliative Maßnahmen

Faiss

Zeitz

2004

Management Des Magen- Und Ösophaguskarzinoms

View full text Add to dashboard Cite

Antireflux stents in tumors of the cardia

Cited by 10 publications

References 30 publications

Stents for benign and malignant esophageal strictures

Stents for benign and malignant esophageal strictures

Stenting in Esophageal Strictures

Interventionelle palliative Maßnahmen

Contact Info

Product

Resources

About